report by BlackRock
Results for ""
Market Outlooks
Global Weekly Commentary: Upgrading our broad U.S. stocks view
This piece is approved to use with clients.
Excitement over artificial intelligence (AI) spurred a rally in U.S. tech stocks that buoyed the market in 2023. We’ve said the rally can run for now – and broaden out.
Market Outlooks
Global Weekly Commentary: Geopolitical fragmentation plays out
This piece is approved to use with clients.
Geopolitical fragmentation, one of five mega forces or structural shifts we track, is playing out in recent events in Asia and the Middle East. Yemen’s Houthi militants attacking Red Sea shipping highlights how hot spots can hit supply chains and up production costs.
Market Outlooks
Global Weekly Commentary: Why stocks can stay upbeat, for now
This piece is approved to use with clients.
Equity markets – and even the Federal Reserve – have largely embraced the soft landing narrative that inflation will fall to the Fed’s 2% target without a recession.
Market Outlooks
Global Weekly Commentary: Navigating macro currents in 2024
This piece is approved to use with clients.
Risk assets ended 2023 on an upbeat note as the Fed appeared to make a big bet on inflation coming down and growth only gradually slowing. Markets interpreted the Fed's messaging as a green light for aggressive policy easing.
Market Outlooks
Global Weekly Commentary: Three 2023 lessons we carry into 2024
This piece is approved to use with clients.
We take three lessons from 2023 to shape our investment approach in the new year. First, markets flipflopping between macro narratives does not reveal new information about where we will end up.
Market Outlooks
US equity outlook: Market breadth to dictate bullishness
This piece is approved to use with clients.
ClearBridge Investments expects market leadership to broaden in 2024 and believe high-quality defensive stocks will hold up better than the current mega cap leaders in an economic downturn.
Market Outlooks
Innovation and consolidation
This piece is approved to use with clients.
Franklin Equity Group believes the road ahead for biotechnology and pharmaceuticals may be different from that of prior years, but as we move into the post-pandemic era, the industry is not lacking innovation prospects.
Market Outlooks
AOR Update: The Fed is Done What's Next?
This piece is approved to use with clients.
Clearbridge Investments: With the market and FOMC suggesting the rate hike cycle is complete, the first interest rate cut could come by May 2024, a pause consistent with the Fed’s “higher for longer” messaging.
Market Outlooks
Flexibility, resilience and opportunity
This piece is approved to use with clients.
Our investment teams share where they see investment opportunities across asset classes in our latest Global Investment Outlook. Is an economic slowdown expected in 2024? Diverse views are presented on interest rates and inflation, investment opportunities, risks, and potential surprises.
Market Outlooks
Stabilization might be enough
This piece is approved to use with clients.
In this Allocation Views, our Franklin Templeton Investment Solutions team see recession risks moderating in some developed economies, led by the United States, but still anticipate a period of below-trend growth to continue into 2024.
Market Outlooks
2024 Outlook: Opportunities in technology
This piece is approved to use with clients.
The information technology sector had an eventful 2023. Franklin Equity Group believes 2024 may be another year of strong performance.
Market Outlooks
AOR Update: The Fed is Done What's Next?
This piece is approved to use with clients.
Clearbridge Investments: With the market and FOMC suggesting the rate hike cycle is complete, the first interest rate cut could come by May 2024, a pause consistent with the Fed’s “higher for longer” messaging.